Lenvima 4mg (Lenvatinib Capsules) 4mg

Lenvima 4mg (Lenvatinib) capsules are prescribed for certain types of cancer. This oral medication is used to treat thyroid cancer, kidney cancer, and liver cancer. It belongs to a class of drugs known as kinase inhibitors. Store at room temperature, away from moisture.

Strength

4mg

Pack Size

20s

Storage

Ambient

Manufacturer / TM Owner

Patheon Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Lenvatinib 4mg capsules are used to treat advanced thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma in adults. It works by slowing or stopping the growth of cancer cells. Patients often ask, 'what is Lenvatinib 4mg used for?' to understand its role in cancer treatment. This medication is part of a broader approach to managing these conditions.

Side Effects

Lenvatinib 4mg capsules may cause side effects such as fatigue, diarrhea, decreased appetite, or nausea. Some users report weight loss or high blood pressure. These effects vary by individual and should be monitored by a healthcare provider. It’s important to report any persistent or severe symptoms promptly.

Precautions & Warnings

Keep Lenvatinib 4mg capsules in their original container at room temperature. Avoid exposure to moisture or heat. Do not crush, chew, or open the capsules unless directed by a healthcare professional. Store in a safe place away from children and pets. Always follow the handling instructions provided with your prescription.

Avoid Interactions

Lenvatinib may interact with other medications, including blood thinners, certain antibiotics, and herbal supplements. Alcohol and grapefruit products may also affect how this medication works. Always inform your doctor about all medications and supplements you are taking to avoid potential interactions.

References

Frequently Asked Questions

Lenvatinib 4mg is used to treat advanced thyroid cancer, kidney cancer, and liver cancer in adults.

Store Lenvatinib 4mg capsules at room temperature in their original container, away from moisture and heat.

Alcohol may interact with Lenvatinib; consult your healthcare provider before consuming alcohol.

Common side effects include fatigue, diarrhea, decreased appetite, and nausea.

Lenvatinib may harm an unborn baby; discuss risks and precautions with your doctor if pregnant or planning pregnancy.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.